Overview
Joan Frigola practices practicing medicine in Banyoles, Spain.
Ms. Frigola is highly rated in 1 condition, according to our data. Her clinical expertise encompasses Mesothelioma, Lung Cancer, and Non-Small Cell Lung Cancer (NSCLC).
She is actively involved in clinical research, co-authoring 18 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Joan Frigola
Is Joan Frigola a top-rated expert for Mesothelioma?
MediFind is an objective health platform that identifies experts based on real-world data. Joan Frigola is classified as an Advanced expert for Mesothelioma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Joan Frigola participate in research or clinical trials?
Yes. Joan Frigola has published 18 articles and abstracts on conditions like Mesothelioma. You can view a list of Joan Frigola's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- MesotheliomaMs. Frigola isAdvanced. Learn about Mesothelioma.
- Experienced
- Lung CancerMs. Frigola isExperienced. Learn about Lung Cancer.
- Non-Small Cell Lung Cancer (NSCLC)Ms. Frigola isExperienced. Learn about Non-Small Cell Lung Cancer (NSCLC).